Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01513031 · ClinicalTrials.gov registry record · Phase 4
Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation
A Phase 4 study, sponsored by Creighton University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT01513031 is a Phase 4 study that was terminated before completion, run by Creighton University. The registered enrollment target is 9 participants.
The verdict
NCT01513031, a Phase 4 study, was terminated before completion, sponsored by Creighton University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral anti-arrhythmic medication. This study will also identify the reasons people stop taking their anti-arrhythmic therapy. A pharmacist will provide medication counseling about their anti-arrhythmic therapy, then will follow-up by telephone on a monthly basis to assess adherence over one year.
Interventions
- OTHER Education and telephone follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01513031
The ClinicalTrials.gov registry entry for NCT01513031 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Education and telephone follow-up is the first listed.
NCT01513031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01513031 about?
NCT01513031 is a clinical study titled "Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation". The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral anti-arrhythmic medication. This study will also identify the reasons people stop taking their anti...
What is the current status of trial NCT01513031?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2012-01. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01513031?
The interventions under investigation include: Education and telephone follow-up (OTHER).
Who is sponsoring clinical trial NCT01513031?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.